ArticlePharmaceutics2026
Nanostructured Lipid Microparticles as Tobramycin Carriers for Pulmonary Drug Delivery.
Katarzyna Reczyńska-Kolman, Jan Grabiński, Konrad Kwiecień, Dorota Ochońska, Kinga Pielichowska, Monika Brzychczy-Włoch, Elżbieta Pamuła
Abstract read
In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Katarzyna Reczyńska-KolmanDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Al. Mickiewicza 30, 30-059 Kraków, Poland.
Jan GrabińskiFaculty of Electrical Engineering, Automatics, Computer Science and Biomedical Engineering, AGH University of Krakow, Al. Mickiewicza 30, 30-059 Kraków, Poland.
Konrad KwiecieńDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Al. Mickiewicza 30, 30-059 Kraków, Poland.
Dorota OchońskaDepartment of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 18 Czysta Street, 31-121 Kraków, Poland.
Kinga PielichowskaDepartment of Glass Technology and Amorphous Coatings, Faculty of Materials Science and Ceramics, AGH University of Krakow, Al. Mickiewicza 30, 30-059 Kraków, Poland.ORCID 0000-0002-5049-8869 Monika Brzychczy-WłochDepartment of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 18 Czysta Street, 31-121 Kraków, Poland.
Elżbieta PamułaDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Al. Mickiewicza 30, 30-059 Kraków, Poland.ORCID 0000-0002-0464-6189 Funding
Ministry of Science and Higher Education "Excellence Initiative-Research University" and the subsidy for the AGH University of KrakowNational Science Centre 2025/56/Q/ST5/00240
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
fatty acidslower respiratory tract infectionsmicroparticlesnanostructured lipid carrierstobramycin
Identifiers
PMID42797237
PMCPMC13610174
What OpenQuestion holds
Textmetadata
Read underepoch 390